Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodney J Scott

Showing results (251-260 of 461) with videos related to

Pageof 47
Sort By:
Clinical Genetics|February 15, 2017
Use of multigene-panel identifies pathogenic variants in several CRC-predisposing genes in patients previously tested for Lynch SyndromeMaren F Hansen, Jostein Johansen, Anna E Sylvander, et al.
NPJ Breast Cancer|January 18, 2022
Integration of tumour sequencing and case-control data to assess pathogenicity of RAD51C missense variants in familial breast cancerBelle W X Lim, Na Li, Simone M Rowley, et al.
Cancer Causes & Control : CCC|December 17, 2013
Exposure to household painting and floor treatments, and parental occupational paint exposure and risk of childhood brain tumors: results from an Australian case-control studyKathryn R Greenop, Susan Peters, Lin Fritschi, et al.
Breast Cancer Research and Treatment|April 11, 2009
BRCA1-associated breast and ovarian cancer risks in Poland: no association with commonly studied polymorphismsAnna Jakubowska, Jacek Gronwald, Janusz Menkiszak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2016
Panel Testing for Familial Breast Cancer: Calibrating the Tension Between Research and Clinical CareElla R Thompson, Simone M Rowley, Na Li, et al.
Frontiers in Immunology|June 16, 2023
Interferon beta treatment is a potent and targeted epigenetic modifier in multiple sclerosisAlexandre Xavier, Maria Pia Campagna, Vicki E Maltby, et al.
Elife|March 15, 2021
Genetic association and causal inference converge on hyperglycaemia as a modifiable factor to improve lung functionWilliam R Reay, Sahar I El Shair, Michael P Geaghan, et al.
Molecular & Cellular Proteomics : MCP|June 5, 2015
Proteotranscriptomic Profiling of 231-BR Breast Cancer Cells: Identification of Potential Biomarkers and Therapeutic Targets for Brain MetastasisMatthew D Dun, Robert J Chalkley, Sam Faulkner, et al.
Circulation|December 22, 2023
Using Genetics to Inform Interventions Related to Sodium and Potassium in HypertensionWilliam R Reay, Erin Clarke, Shaun Eslick, et al.
Clinical Epigenetics|February 11, 2023
Parity is associated with long-term differences in DNA methylation at genes related to neural plasticity in multiple sclerosisMaria Pia Campagna, Alexandre Xavier, Jim Stankovich, et al.
Pageof 47

Showing results (251-260 of 461) with videos related to

Sort By:
Pageof 47
Clinical Genetics|February 15, 2017
Use of multigene-panel identifies pathogenic variants in several CRC-predisposing genes in patients previously tested for Lynch SyndromeMaren F Hansen, Jostein Johansen, Anna E Sylvander, et al.
NPJ Breast Cancer|January 18, 2022
Integration of tumour sequencing and case-control data to assess pathogenicity of RAD51C missense variants in familial breast cancerBelle W X Lim, Na Li, Simone M Rowley, et al.
Cancer Causes & Control : CCC|December 17, 2013
Exposure to household painting and floor treatments, and parental occupational paint exposure and risk of childhood brain tumors: results from an Australian case-control studyKathryn R Greenop, Susan Peters, Lin Fritschi, et al.
Breast Cancer Research and Treatment|April 11, 2009
BRCA1-associated breast and ovarian cancer risks in Poland: no association with commonly studied polymorphismsAnna Jakubowska, Jacek Gronwald, Janusz Menkiszak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2016
Panel Testing for Familial Breast Cancer: Calibrating the Tension Between Research and Clinical CareElla R Thompson, Simone M Rowley, Na Li, et al.
Frontiers in Immunology|June 16, 2023
Interferon beta treatment is a potent and targeted epigenetic modifier in multiple sclerosisAlexandre Xavier, Maria Pia Campagna, Vicki E Maltby, et al.
Elife|March 15, 2021
Genetic association and causal inference converge on hyperglycaemia as a modifiable factor to improve lung functionWilliam R Reay, Sahar I El Shair, Michael P Geaghan, et al.
Molecular & Cellular Proteomics : MCP|June 5, 2015
Proteotranscriptomic Profiling of 231-BR Breast Cancer Cells: Identification of Potential Biomarkers and Therapeutic Targets for Brain MetastasisMatthew D Dun, Robert J Chalkley, Sam Faulkner, et al.
Circulation|December 22, 2023
Using Genetics to Inform Interventions Related to Sodium and Potassium in HypertensionWilliam R Reay, Erin Clarke, Shaun Eslick, et al.
Clinical Epigenetics|February 11, 2023
Parity is associated with long-term differences in DNA methylation at genes related to neural plasticity in multiple sclerosisMaria Pia Campagna, Alexandre Xavier, Jim Stankovich, et al.
Pageof 47